- ICH GCP
- US Clinical Trials Registry
- Klinisk forsøg NCT00276198
Efficacy Trial to Examine Efficacy of Multimicronutrient Home Supplementation in Infants
Controlled Clinical Trial to Assess the Effect of Multiple Micronutrient Supplementation (Iron, Vitamins A, C, D, Folic Acid and Zinc) on Nutritional and Health Indicators in Infants in Southern Israel.
Studieoversigt
Status
Betingelser
Intervention / Behandling
Detaljeret beskrivelse
The high level of anemia persists in Negev children despite the existence of a policy of the Ministry of Health that calls for Iron, Vitamin A and Vitamin D supplementation up to 12 months of age. In addition, other micronutrient deficiencies in this population have been described in several studies. These may be related to; low adherence with existing recommendations; need for additional micronutrients other than Iron, Vitamin A and Vitamin D; the need for a different delivery system more acceptable to mothers and infants.
We will compare in Bedouin and Jewish children separately the efficacy of daily use of Sprinkles(home Micronutrient fortification) from age 6 to 12 months in infants recruited in Maternal and Child Health clinics.
The comparison will be children recruited in clinics of comparable socioeconomic status, where current Ministry of Health recommendations (drops of iron and vitamins A plus D) are the treatment regimen.
Undersøgelsestype
Tilmelding (Forventet)
Fase
- Fase 3
Kontakter og lokationer
Studiesteder
-
-
-
Beer-Sheva, Israel, 10050
- Ministry of Health
-
-
Deltagelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Infant aged 5-7 months
- Infant whose parents give their written informed consent
- Infants whose parents intend to reside within the area for at least 12 months
- Infants receiving any additional food besides breast feeding
Exclusion Criteria:
- Known or suspected haemotological disorders
- Known or suspected anemia (Hb <11 gr/dl)
- Known or suspected immunological disorders
- Known or suspected malabsorption disorders
- Enrolled or scheduled to be enrolled in another clinical trial
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Forebyggelse
- Tildeling: Randomiseret
- Interventionel model: Parallel tildeling
- Maskning: Ingen (Åben etiket)
Våben og indgreb
Deltagergruppe / Arm |
Intervention / Behandling |
|---|---|
|
Eksperimentel: 1
Supplementation with daily sprinkle package
|
Daily dosage of fat coated iron (desote fumarate) 12.5 mg, zinc 5mg, vitamin A 300 micrograms, folic acid 150 micrograms, ascorbic acid 50 mg.
|
|
Aktiv komparator: 2
Supplementation with Iron tonic 15mg, vitamins A 300 micrograms, vitamin D 10 micrograms.
According to Ministry of Health routine recommendations.
|
Daily dosage of Iron tonic 15mg, vitamins A 300 micrograms, vitamin D 10 micrograms once a day from age 6 months up to age 12 months
Andre navne:
|
|
Ingen indgriben: 3
No intervention except for checking outcomes at approprite times.
|
Hvad måler undersøgelsen?
Primære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Haemotological parameters (haemoglobin, transferrin saturation, and ferritin)
Tidsramme: 12, 18 and 24 months
|
12, 18 and 24 months
|
|
Micronutrient status (Iron, Zinc and B12 and Folic acid level)
Tidsramme: 12, 18 months
|
12, 18 months
|
|
Incidence of infectious diseases total morbidity (IDTM) due to respiratory tract infections, diarrhea, sepsis, otitis media, cutaneous infections, fever) and all illnesses (ACTM)
Tidsramme: 12, 18, 24 months
|
12, 18, 24 months
|
|
Health Care Services use (primary care clinics visits, emergency room visits, hospitalizations
Tidsramme: 24 months
|
24 months
|
Sekundære resultatmål
Resultatmål |
Tidsramme |
|---|---|
|
Reported morbidity due to infectious diseases (lower respiratory tract infections, diarrhea, sepsis, otitis media, cutaneous infections, fever)
Tidsramme: 12, 18, 24 months
|
12, 18, 24 months
|
|
Growth parameters (WAZ, HAZ, WHZ)
Tidsramme: 12, 18, 24 months
|
12, 18, 24 months
|
|
Safety, diarrhea, constipation, color, smell and form of stool changes. Any other adverse events.
Tidsramme: 12 months
|
12 months
|
Samarbejdspartnere og efterforskere
Sponsor
Efterforskere
- Ledende efterforsker: Drora Fraser, PhD, Ben-Gurion University of the Negev
Publikationer og nyttige links
Generelle publikationer
Hjælpsomme links
Datoer for undersøgelser
Studer store datoer
Studiestart
Primær færdiggørelse (Faktiske)
Studieafslutning (Faktiske)
Datoer for studieregistrering
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først opslået (Skøn)
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Skøn)
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Yderligere relevante MeSH-vilkår
- Patologiske processer
- Metaboliske sygdomme
- Sygdomsegenskaber
- Hæmatologiske sygdomme
- Ernæringsforstyrrelser
- Anæmi, hypokromisk
- Anæmi
- Forstyrrelser i jernmetabolisme
- Infektioner
- Overførbare sygdomme
- Anæmi, jernmangel
- Fejlernæring
- Lægemidlers fysiologiske virkninger
- Mikronæringsstoffer
- Vitaminer
- Knogletæthedsbevarende midler
- D-vitamin
- Vitamin A
Andre undersøgelses-id-numre
- sor395705ctil
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .